Table 3.
CI and dose reduction values for inhibition on A549, H1957 and PC9 by combining doxorubicin with apatinib
| % Inhibition | CI | Doxorubicin | Apatinib | |||||
|---|---|---|---|---|---|---|---|---|
| Conc.:(μmol/L) | Dose reduction |
Conc.:(μmol/L) | Dose reduction |
|||||
| Alone | Mix | Alone | Mix | |||||
| A549 | ||||||||
| 50 | 0.8545 | 0.784 | 0.523 | 1.499 | 28.998 | 4.445 | 6.523 | |
| 75 | 1.0332 | 1.245 | 0.971 | 1.282 | 39.449 | 8.162 | 4.833 | |
| 95 | 0.9853 | 1.879 | 1.435 | 1.309 | 54.518 | 12.751 | 4.276 | |
| NCI-H1975 | ||||||||
| 50 | 0.5675 | 0.872 | 0.231 | 3.775 | 13.193 | 1.242 | 10.622 | |
| 75 | 0.6121 | 1.411 | 0.476 | 2.964 | 23.643 | 4.116 | 5.744 | |
| 95 | 0.6798 | 1.942 | 0.712 | 2.728 | 39.532 | 5.532 | 7.146 | |
| PC9 | ||||||||
| 50 | 1.1964 | 0.214 | 0.201 | 1.209 | 24.682 | 1.888 | 13.073 | |
| 75 | 1.0532 | 0.387 | 0.329 | 1.294 | 38.784 | 2.843 | 13.641 | |
| 95 | 1.1723 | 0.512 | 0.483 | 1.270 | 51.343 | 4.032 | 12.733 | |